Dai-ichi Life Holdings, Inc.
DCNSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.23 | -0.39 | 0.34 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -1,240.87 | 4,659.07 | 3,857.83 | 2,827.50 |
| Quality | ||||
| ROIC | 1.75% | 0.00% | 2.30% | 2.34% |
| Gross Margin | 0.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -9.77% | 1.52% | 2.62% | 3.42% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -1,259.57 | -2,152.43 | -2,817.99 | -753.91 |
| Interest Coverage | 3.29 | 13.29 | 119.73 | 219.35 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 90.10 | 0.00 |